Sequential therapy with alternating short courses of R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, prednisone) and R-FM (rituximab, fludarabine, mitoxantrone) followed by autologous stem cell transplantation results in long term remission in advanced follicular lymphoma

Br J Haematol. 2014 Aug;166(4):625-8. doi: 10.1111/bjh.12894. Epub 2014 Apr 18.
No abstract available

Keywords: autologous stem cell transplantation; follicular lymphoma; sequential therapy.

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Antibodies, Monoclonal, Murine-Derived / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Combined Modality Therapy / methods
  • Cyclophosphamide / administration & dosage
  • Doxorubicin / administration & dosage
  • Epothilones / administration & dosage
  • Female
  • Humans
  • Lymphoma, Follicular / therapy*
  • Male
  • Middle Aged
  • Mitoxantrone / administration & dosage
  • Prednisone / administration & dosage
  • Rituximab
  • Stem Cell Transplantation / methods*
  • Transplantation, Autologous
  • Treatment Outcome
  • Vincristine / administration & dosage

Substances

  • Antibodies, Monoclonal, Murine-Derived
  • Epothilones
  • R-CHOP protocol
  • fludelone
  • Rituximab
  • Vincristine
  • Doxorubicin
  • Cyclophosphamide
  • Mitoxantrone
  • Prednisone